{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:54:26Z","timestamp":1789689266746,"version":"4.0.1"},"reference-count":17,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.3892\/etm_00000090","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T11:27:59Z","timestamp":1276169279000},"page":"575-577","source":"Crossref","is-referenced-by-count":12,"title":["Bleeding diathesis is associated with an A15T heterozygous mutation in exon 2 of the plasminogen activator inhibitor type 1"],"prefix":"10.3892","volume":"1","author":[{"given":"JERZY","family":"JANKUN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EWA","family":"SKRZYPCZAK-JANKUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2010,7,1]]},"reference":[{"key":"key20180108131333_b1-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00125-003-1170-0","article-title":"PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population","volume":"46","author":"Lopes","year":"2003","journal-title":"Diabetologia"},{"key":"key20180108131333_b2-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00001721-200501000-00013","article-title":"A case of deficiency of plasma plasminogen activator inhibitor-1 related to Ala15Thr mutation in its signal peptide","volume":"16","author":"Zhang","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"key20180108131333_b3-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/blood.V90.1.204","article-title":"Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene","volume":"90","author":"Fay","year":"1997","journal-title":"Blood"},{"key":"key20180108131333_b4-etm-01-04-0575","first-page":"267","article-title":"Studies of whole blood coagulation by oscillatory shear, thromboelastography and free oscillation rheometry","volume":"38","author":"Evans","year":"2008","journal-title":"Clin Hemorheol Microcirc"},{"key":"key20180108131333_b5-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1111\/j.1538-7836.2005.01615.x","article-title":"Urokinase induced fibrinolysis in thromboelastography: a model for studying fibrinolysis and coagulation in whole blood","volume":"3","author":"Gallimore","year":"2005","journal-title":"J Thromb Haemost"},{"key":"key20180108131333_b6-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-0038-1648389","article-title":"Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis","volume":"67","author":"Carr","year":"1992","journal-title":"Thromb Haemost"},{"key":"key20180108131333_b7-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/0041-0101(95)00102-6","article-title":"Enhancement of plasma fibrinolysis in vitro by jararhagin, the main haemorrhagic metalloproteinase in Bothrops jararaca venom","volume":"33","author":"Sugiki","year":"1995","journal-title":"Toxicon"},{"key":"key20180108131333_b8-etm-01-04-0575","first-page":"683","article-title":"Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis","volume":"20","author":"Jankun","year":"2007","journal-title":"Int J Mol Med"},{"key":"key20180108131333_b9-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1399-6576.1999.430217.x","article-title":"In vitro effects of propofol on blood coagulability and fibrinolysis by the use of thromboelastograph technique","volume":"43","author":"Kohro","year":"1999","journal-title":"Acta Anaesthesiol Scand"},{"key":"key20180108131333_b10-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/MBC.0b013e3282dded21","article-title":"Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity","volume":"18","author":"Agren","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"key20180108131333_b11-etm-01-04-0575","first-page":"44","article-title":"The effect of chronic allograft rejection on plasma regulators of fibrinolysis","volume":"7","author":"Perkowska","year":"2002","journal-title":"Ann Transplant"},{"key":"key20180108131333_b12-etm-01-04-0575"},{"key":"key20180108131333_b13-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1734-1140(09)70119-7","article-title":"Accelerated thrombus lysis in the blood of plasminogen activator inhibitor deficient mice is inhibited by PAI-1 with a very long half-life","volume":"61","author":"Jankun","year":"2009","journal-title":"Pharmacol Rep"},{"key":"key20180108131333_b14-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2516.2008.01834.x","article-title":"Plasminogen activator inhibitor type 1 deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Haemophilia"},{"key":"key20180108131333_b15-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1172\/JCI114076","article-title":"Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor","volume":"83","author":"Schleef","year":"1989","journal-title":"J Clin Invest"},{"key":"key20180108131333_b16-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"410","DOI":"10.20452\/pamw.729","article-title":"Yin and yang of the plasminogen activator inhibitor","volume":"119","author":"Jankun","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"key20180108131333_b17-etm-01-04-0575","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/107602960401000316","article-title":"Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report and literature review","volume":"10","author":"Repine","year":"2004","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm_00000090\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:42:30Z","timestamp":1740174150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm_00000090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,7,1]]},"published-print":{"date-parts":[[2010]]}},"alternative-id":["10.3892\/etm_00000090"],"URL":"https:\/\/doi.org\/10.3892\/etm_00000090","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}